Efficacy and Safety of CAP7.1 as Second-Line Treatment for Advanced Biliary Tract Cancers: Data from a Randomised Phase II Study

SIMPLE SUMMARY: Advanced biliary tract cancer is difficult to treat, and 5-year survival is less than 5% for tumours that cannot be removed by surgery. CAP7.1 is a drug being investigated for biliary tract cancer. This study assessed treatment with CAP7.1 in patients with advanced biliary tract canc...

Descripción completa

Detalles Bibliográficos
Autores principales: Pape, Ulrich-Frank, Kasper, Stefan, Meiler, Johannes, Sinn, Marianne, Vogel, Arndt, Müller, Lothar, Burkhard, Oswald, Caca, Karel, Heeg, Steffen, Büchner-Steudel, Petra, Rodriguez-Laval, Victor, Kühl, Anja A, Arsenic, Ruza, Jansen, Holger, Treasure, Peter, Utku, Nalân
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7692271/
https://www.ncbi.nlm.nih.gov/pubmed/33121007
http://dx.doi.org/10.3390/cancers12113149

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7692271/
https://www.ncbi.nlm.nih.gov/pubmed/33121007
http://dx.doi.org/10.3390/cancers12113149

Ejemplares similares